Published in J Clin Invest on April 01, 1994
A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I. J Cell Biol (1995) 2.53
Binding of the 60-kDa Ro autoantigen to Y RNAs: evidence for recognition in the major groove of a conserved helix. RNA (1998) 1.29
The levels of the RoRNP-associated Y RNA are dependent upon the presence of ROP-1, the Caenorhabditis elegans Ro60 protein. Genetics (1999) 1.26
Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis (2002) 1.11
Gene encoding human Ro-associated autoantigen Y5 RNA. Nucleic Acids Res (1996) 1.07
Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J Exp Med (1999) 1.02
Emerging roles for the Ro 60-kDa autoantigen in noncoding RNA metabolism. Wiley Interdiscip Rev RNA (2011) 1.02
Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol (1995) 1.01
Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins. RNA (2000) 0.99
Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis (1999) 0.95
Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol (2001) 0.91
The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies. Proc Natl Acad Sci U S A (1997) 0.91
Clinical and pathological roles of Ro/SSA autoantibody system. Clin Dev Immunol (2012) 0.86
Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol (2000) 0.85
Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol (1995) 0.85
Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome. Br J Ophthalmol (2004) 0.79
Immunogenetics of epitopes of the carboxyl terminus of the human 60-kD Ro autoantigen. Clin Exp Immunol (1995) 0.78
Autoantibodies to the RoRNP particles. Clin Exp Immunol (1995) 0.76
Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig Dis Sci (1998) 0.76
Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J Histochem Cytochem (1974) 20.88
Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. Cell (1983) 17.60
Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1979) 14.61
Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates. J Biol Chem (1979) 11.68
Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc Natl Acad Sci U S A (1981) 10.72
RNA recognition: towards identifying determinants of specificity. Trends Biochem Sci (1991) 9.03
Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1981) 7.43
Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science (1981) 6.34
Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol (1981) 4.41
A novel cysteine-rich sequence motif. Cell (1991) 4.39
Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum (1976) 4.02
Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies. Cell (1982) 3.76
The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A (1984) 3.51
A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med (1988) 2.98
Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single-copy in the human genome. Cell (1983) 2.40
Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem (1988) 2.37
Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest (1991) 2.28
Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci U S A (1988) 2.11
Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A (1985) 2.07
Analysis of protein--RNA interactions within Ro ribonucleoprotein complexes. Nucleic Acids Res (1991) 1.76
Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding. Nucleic Acids Res (1989) 1.72
Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. J Clin Invest (1989) 1.59
Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest (1989) 1.41
Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest (1991) 1.38
A subset of hY RNAs is associated with erythrocyte Ro ribonucleoproteins. EMBO J (1990) 1.34
Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J Mol Biol (1992) 1.31
Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum (1990) 1.28
Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.26
Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest (1990) 1.22
Mg2+ induces a sharp and reversible transition in U1 and U2 small nuclear ribonucleoprotein configurations. Mol Cell Biol (1984) 1.21
Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle. J Clin Invest (1989) 1.18
Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol (1991) 1.14
Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity (1992) 1.12
Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: Antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. Autoimmunity (1992) 0.93
Sjögren's syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes. J Autoimmun (1989) 0.93
The particulate (speckled-like thread) nuclear staining pattern: species and cellular distribution of Ro/SSA antigen. J Clin Lab Immunol (1987) 0.82
RNA recognition: towards identifying determinants of specificity. Trends Biochem Sci (1991) 9.03
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell (1989) 7.42
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A (2000) 4.99
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol (1993) 4.63
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol (1997) 3.21
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet (1997) 3.05
Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci U S A (1994) 2.95
RNA-binding domain of the A protein component of the U1 small nuclear ribonucleoprotein analyzed by NMR spectroscopy is structurally similar to ribosomal proteins. Proc Natl Acad Sci U S A (1991) 2.87
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc Natl Acad Sci U S A (1990) 2.76
ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev (1999) 2.65
A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell (1987) 2.58
U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res (1991) 2.49
Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem (1988) 2.37
Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A' protein. Mol Cell Biol (1991) 2.33
Hel-N1/Hel-N2 proteins are bound to poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci (1996) 2.18
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell (1983) 2.14
Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci U S A (1988) 2.11
Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor. J Neurosci (1994) 2.09
Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A (1985) 2.07
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Sequence-specific contacts between the RNA polymerase of vesicular stomatitis virus and the leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.95
Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol Cell Biol (1994) 1.94
Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus. J Cell Sci (1998) 1.94
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
The U1 RNA-binding site of the U1 small nuclear ribonucleoprotein (snRNP)-associated A protein suggests a similarity with U2 snRNPs. Mol Cell Biol (1989) 1.87
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol (1984) 1.75
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
A specific 31-nucleotide domain of U1 RNA directly interacts with the 70K small nuclear ribonucleoprotein component. Mol Cell Biol (1989) 1.68
Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem (2000) 1.54
Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Association between the 7 S RNA and the lupus La protein varies among cell types. J Biol Chem (1983) 1.51
In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. Proc Natl Acad Sci U S A (1992) 1.50
A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1983) 1.50
Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene (2008) 1.41
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles. Proc Natl Acad Sci U S A (1977) 1.40
Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) (2004) 1.40
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions. Mol Cell Biol (1991) 1.37
Rapid and transient localization of the leader RNA of vesicular stomatitis virus in the nuclei of infected cells. Proc Natl Acad Sci U S A (1982) 1.35
RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus. J Virol (1982) 1.34
Exploring molecular diversity with combinatorial shape libraries. Trends Biochem Sci (1994) 1.33
Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol Cell Biol (1987) 1.29
A sequence-specific conformational epitope on U1 RNA is recognized by a unique autoantibody. Proc Natl Acad Sci U S A (1988) 1.26
Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol Chem (2000) 1.26
Nature of the 3'-terminal sequences of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2 and 3. Virology (1980) 1.22
Overexpression of the arginine-rich carboxy-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev (1995) 1.21
Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol (1985) 1.20
Autoantibodies specific for U1 RNA and initiator methionine tRNA. J Biol Chem (1986) 1.15
In vitro selection of aptamers from RNA libraries. Methods Mol Biol (1999) 1.12
Base mutations in the terminal noncoding regions of the genome of vesicular stomatitis virus isolated from persistent infections of L cells. Virology (1985) 1.11
The plus strand of reovirus gene S2 is identical with its in vitro transcript. Virology (1980) 1.09
The U1 small nuclear ribonucleoprotein (snRNP) 70K protein is transported independently of U1 snRNP particles via a nuclear localization signal in the RNA-binding domain. Mol Cell Biol (1994) 1.09
Sequential synthesis of small capped RNA transcripts in vitro by vesicular stomatitis virus. Virology (1983) 1.08
RNA binding specificity of a Drosophila snRNP protein that shares sequence homology with mammalian U1-A and U2-B" proteins. Nucleic Acids Res (1992) 1.07
Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res (1991) 1.07
Analysis of autoantibody binding to different regions of the human La antigen expressed in recombinant fusion proteins. J Immunol (1988) 1.00
Antigenicity of a recombinant Ro (SS-A) fusion protein. Arthritis Rheum (1990) 0.96
RNA sequence and transcriptional properties of the 3' end of the Newcastle disease virus genome. Virology (1985) 0.95
Anti-La antibody production by MRL-1pr/1pr mice. Analysis of fine specificity. J Immunol (1991) 0.94
The metabolic fate of independently initiated VSV mRNA transcripts. J Gen Virol (1982) 0.92
In vitro selection of RNA epitopes using autoimmune patient serum. J Immunol (1993) 0.91
Temporal correlation of antibody responses to different epitopes of the human La autoantigen. J Clin Invest (1990) 0.90
Quantitative immunoassay of anti-La antibodies using purified recombinant La antigen. Arthritis Rheum (1988) 0.89
Alu RNA-protein complexes formed in vitro react with a novel lupus autoantibody. J Biol Chem (1985) 0.89
Transfer RNAs associated with vesicular stomatitis virus. J Gen Virol (1981) 0.89
Association of 3' terminal RNA sequences with avian leukosis viruses causing a high incidence of osteopetrosis. Virology (1982) 0.87
Identification of specific protein-RNA target sites using libraries of natural sequences. Methods Mol Biol (1999) 0.87
A comparison of the extents of methylation of vesicular stomatitis virus messenger RNA. Virology (1976) 0.87
60-kDa Ro protein autoepitopes identified using recombinant polypeptides. J Immunol (1994) 0.85
Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3' UTR. Nucleic Acids Symp Ser (1995) 0.84
Downregulation of RNA polymerase III transcription of the hY3 gene in vitro. Mol Biol Rep (1990) 0.83
Replication of the vesicular stomatitis virus genome in permissive and nonpermissive host cells. J Biol Chem (1985) 0.83
Interactions of plus and minus strand leader RNAs of the New Jersey serotype of vesicular stomatitis virus with the cellular La protein. Virology (1984) 0.82
Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins. J Virol (1989) 0.81
Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosus. Clin Immunol Immunopathol (1990) 0.81
Molecular biology of nuclear autoantigens. Rheum Dis Clin North Am (1992) 0.80
The fine specificity of anti-La antibodies induced in mice by immunization with recombinant human La autoantigen. J Immunol (1990) 0.79
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1995) 0.79
Characterization of a Drosophila U snRNP RNA-binding protein. Mol Biol Rep (1990) 0.77
Inhibitory effects of vesicular stomatitis virus on cellular and influenza viral RNA metabolism and protein synthesis. Virology (1989) 0.76
A three allele TaqI polymorphism at TOP1 gene. Nucleic Acids Res (1990) 0.75
Combinatorial chemistry. Curr Biol (1998) 0.75
The sequence at the termini of four genes of the three reovirus serotypes. Virology (1982) 0.75
Epitope specificity of anti-La antibodies from patients with Sjögren's syndrome. J Autoimmun (1989) 0.75
Conservation of the 3' terminal nucleotide sequences of Ebola and Marburg virus. Virology (1986) 0.75